Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Braxia Scientific Corp > SHRMF Back from dead?
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(167)
•••
Comment by newcoinon Sep 26, 2020 12:00pm
303 Views
Post# 31625316

RE:RE:RE:RE:RE:RE:RE:RE:SHRMF Back from dead?

RE:RE:RE:RE:RE:RE:RE:RE:SHRMF Back from dead?You are very welcome.

In hind sight, we all should have sold when SHRM was trading over $2.00 and bought back under $1.00.

However, no one knows the future and this happens to all of us.

All you can do is wait it out. Shrm will be trading again soon.

As soon as the news comes out we can all begin to get our portfolios in order.

GLTA




CMOREGAINS wrote: Thanks for this vote of confidence! This is how I felt when I initially invested. I've just been down because the market has been terrible and I didn't sell out of quite a few stocks that were way up in August on the Rally. I got greedy and held when I should of sold quite a few of my holdings. I feel like I'm being held hostage on some of my bad investments which isn't fun. Zig and Zag the market is a drag. 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities